| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $48,335,307 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA259686 | A tissue viability imaging biomarker for use in non-invasive breast cancer therapy | 000 | 4 | NIH | 12/23/2024 | $549,903 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01MH128187 | The role of distributional reinforcement learning in human neurons during impulsive choices | 000 | 4 | NIH | 1/7/2025 | $420,363 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R03DK138251 | Sympathetic Activation of Renal Dendritic Cells in Hypertension | 000 | 2 | NIH | 12/23/2024 | $103,950 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL166733 | Biomarkers of Habitual Short Sleep and Related Cardiometabolic Risk | 000 | 2 | NIH | 1/14/2025 | $26,622 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG061376 | The Role of the Lysosome in Aging | 000 | 7 | NIH | 1/13/2025 | $403,709 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG076748 | Tissue senescence and age-associated metabolic dysfunction: the role of immune cell mediated inflammation | 000 | 3 | NIH | 12/20/2024 | $401,253 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31HL178200 | Myocarditis is necessary for the development of arrhythmogenic cardiomyopathy | 000 | 1 | NIH | 12/20/2024 | $37,045 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U24HL147018 | 2/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED) | 000 | 5 | NIH | 11/26/2024 | $505,281 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AR083686 | Quantitative magnetic resonance imaging in patients with femoroacetabular impingement syndrome | 000 | 2 | NIH | 12/4/2024 | $243,936 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21EB035378 | A gaze-controlled neck exoskeleton for dropped head syndrome | 000 | 2 | NIH | 12/26/2024 | $165,280 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K24AG080168 | Using pharmacoepidemiology to optimize antihypertensive medication use to prevent aging-related multimorbidity: Midcareer investigator award in patient-oriented research and mentoring. | 000 | 3 | NIH | 2/19/2025 | $198,213 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23HL157751 | A theory-based practice guide for creating patient education | 000 | 4 | NIH | 2/20/2025 | $149,623 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HG012286 | Calypso: a web software system supporting team-based, longitudinal genomic diagnostic care | 000 | 4 | NIH | 2/27/2025 | $803,674 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F32HL177926 | The impact of pyruvate metabolic fate in myofibroblast differentiation in myelofibrosis. | 001 | 1 | NIH | 12/27/2024 | $0 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R00MH121563 | Determining the role of amygdalostriatal transition zone circuits in associative learning and motivated behaviors | 000 | 4 | NIH | 2/19/2025 | $211,650 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31CA271740 | Investigating the regulation and mechanism of tension-sensors Stu2 & Ndc80c | 000 | 3 | NIH | 2/19/2025 | $43,133 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23EY032577 | Improving Glaucoma Care Using a Scalable Decision Support System | 000 | 4 | NIH | 2/20/2025 | $270,321 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30CA260977 | T cell expressed miR-155 promotes antitumor immunity and immune checkpoint blockade responses in colon cancer through repression of Ship1 | 000 | 5 | NIH | 3/13/2025 | $56,974 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U01DA041134 | 1/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT U UTAH | 001 | 11 | NIH | 3/12/2025 | $420,761 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U01DA041134 | 1/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT U UTAH | 001 | 11 | NIH | 3/12/2025 | $2,035,408 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EY028927 | Retinal Circuitry | 000 | 6 | NIH | 3/13/2025 | $685,322 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA240612 | Biology and Targeting of noncoding RNAs in AML | 000 | 5 | NIH | 3/13/2025 | $317,048 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM141262 | Elucidating roles and mechanisms of double-stranded RNA-mediated pathways | 001 | 5 | NIH | 3/20/2025 | $543,510 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K08CA252883 | Mechanisms of resistance to MEK Inhibition in RAS-pathway activated chronic myelomonocytic leukemia | 000 | 4 | NIH | 3/13/2025 | $289,908 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DC021938 | Biomechanical Mechanisms of Benign Paroxysmal Positional Vertigo | 000 | 1 | NIH | 3/19/2025 | $514,546 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R37AI051174 | Biochemistry of HIV-1 Budding | 000 | 24 | NIH | 3/20/2025 | $557,086 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG083580 | Geriatric assessment domains in relation to treatment outcomes among older adults with colorectal cancer | 000 | 2 | NIH | 3/20/2025 | $697,349 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | UG1HD034208 | UofU Maternal-Fetal Medicine Units (MFMU) Network: Clinical Centers | 000 | 31 | NIH | 3/28/2025 | $321,101 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21DC022648 | Neural basis of precedence-type sound localization processes | 000 | 1 | NIH | 3/20/2025 | $189,530 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F32DC022517 | Utilizing Receptor-defined Odor Coding Channels to Understand Inhibitory Circuit Organization | 000 | 1 | NIH | 3/20/2025 | $74,284 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL162353 | Improved Imaging of Fibrosis in Atrial Fibrillation | 000 | 4 | NIH | 3/28/2025 | $560,273 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AR083990 | Novel Zinc-Finger Protein Regulator of Senescence and Cell Engineering | 000 | 2 | NIH | 3/20/2025 | $376,768 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI162929 | Targeting OCA-B in multiple sclerosis | 000 | 4 | NIH | 1/9/2025 | $399,740 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL167866 | Pathobiological mechanisms of cardiac disease in PGM1-CDG | 000 | 2 | NIH | 11/14/2024 | $586,682 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM153175 | Out of the shadows: Illuminating mammalian histidine phosphorylation | 001 | 2 | NIH | 1/8/2025 | $346,500 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01MH132822 | Prefrontal Circuit Control of Isolation-Induced Aggression | 000 | 3 | NIH | 2/13/2025 | $486,185 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R00EY032119 | Bridging gap in comparative biology using the tree shrew visual system | 000 | 5 | NIH | 2/14/2025 | $249,000 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01GM144719 | “Conus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discovery” | 000 | 4 | NIH | 3/25/2025 | $517,563 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA176839 | Targeting Oncogenic NRAS, BRAF plus PI3'-Kinase Signaling for Melanoma Therapy | 000 | 8 | NIH | 3/7/2025 | $346,500 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK133270 | Share plus: Continuous Glucose Monitoring with Data Sharing in Older Adults with T1D and Their Care Partners | 000 | 3 | NIH | 2/21/2025 | $277,200 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HD107077 | Economic security policy and birth outcomes among socio-economically disadvantaged women | 000 | 3 | NIH | 3/3/2025 | $289,596 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EY036877 | The role of centriole linkage in retinal degeneration and hearing loss | 000 | 1 | NIH | 2/21/2025 | $462,430 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL178117 | Assessing myocardial fibrosis with spin locked MRI | 000 | 1 | NIH | 3/10/2025 | $756,947 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | T35DK103596 | MSRP in Metabolism, Diabetes, Digestive and Kidney Diseases | 000 | 10 | NIH | 3/3/2025 | $44,200 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R03EB037114 | Albumin-Amended Antibody Drug Conjugate (A3DC) for Immunosuppression | 000 | 1 | NIH | 3/25/2025 | $77,000 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK135968 | Beta-cell self-antigen recognition by diabetogenic CD8 T cells | 000 | 3 | NIH | 2/21/2025 | $346,500 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | UG1CA233178 | Huntsman Cancer Institute/ University of Utah Network Lead Academic Participating Site Application | 002 | 6 | NIH | 3/10/2025 | $301,967 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA289731 | The combined role of ARID1A loss and estrogen signaling in endometrial cancer | 000 | 2 | NIH | 3/4/2025 | $380,042 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R37NS102978 | Noncanonical glutamate signaling in the origins of the migraine attack | 000 | 7 | NIH | 3/4/2025 | $605,840 |
|
